Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

Journal of Cardiovascular Electrophysiology - United Kingdom
doi 10.1111/jce.14335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Atrial Fibrillation and Coronary Artery Disease: Resembling Twins?

Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Epicardial Fat in Coronary Artery Disease and Atrial Fibrillation

Cardiologia Croatica
Cardiovascular MedicineCardiology
2018English

Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation

American Heart Journal
Cardiovascular MedicineCardiology
2013English

Effects of E-4031 on Atrial Fibrillation Threhold: A Comparative Study With Class I Antiarrhythmic Drugs.

Japanese Journal of Electrocardiology
1994English

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation

JAMA - Journal of the American Medical Association
Medicine
2005English

Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Antiarrhythmic Effects of the Class 1c Antiarrhythmic Drug, Flecainide, on Canine Ventricular Arrhythmia Models.

Japanese Heart Journal
1989English

Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy